Zemaira - 0053-7201-02 - (alpha-1-proteinase inhibitor human)

Alphabetical Index


Drug Information of Zemaira

Product NDC: 0053-7201
Proprietary Name: Zemaira
Non Proprietary Name: alpha-1-proteinase inhibitor human
Active Ingredient(s):    & nbsp;   alpha-1-proteinase inhibitor human
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Zemaira

Product NDC: 0053-7201
Labeler Name: CSL Behring LLC
Product Type: PLASMA DERIVATIVE
FDA Application Number: BLA125078
Marketing Category: BLA
Start Marketing Date: 20030708

Package Information of Zemaira

Package NDC: 0053-7201-02
Package Description: 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20)

NDC Information of Zemaira

NDC Code 0053-7201-02
Proprietary Name Zemaira
Package Description 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20)
Product NDC 0053-7201
Product Type Name PLASMA DERIVATIVE
Non Proprietary Name alpha-1-proteinase inhibitor human
Dosage Form Name KIT
Route Name
Start Marketing Date 20030708
Marketing Category Name BLA
Labeler Name CSL Behring LLC
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Zemaira


General Information